IRWD - Ironwood Pharmaceuticals Inc

Insider Sale by Silver Ronald (Principal Accounting Officer)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Silver Ronald, serving as Principal Accounting Officer at Ironwood Pharmaceuticals Inc (IRWD), sold 24,173 shares at $3.73 per share, for a total transaction value of $90,206.00. Following this transaction, Silver Ronald now holds 252,636 shares of IRWD.

This sale represents a 9.00% decrease in Silver Ronald's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 25, 2026, 2 days after the trade was made.

Ironwood Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Silver Ronald

Principal Accounting Officer

Ronald Silver is the Principal Accounting Officer at Ironwood Pharmaceuticals Inc. (IRWD), a role in which he oversees key financial reporting and compliance functions.[[1]](https://www.ainvest.com/news/ironwood-pharmaceuticals-announces-principal-accounting-officer-silver-ronald-35-416-share-sale-2601/)[[2]](https://www.stocktitan.net/sec-filings/IRWD/form-4-ironwood-pharmaceuticals-inc-insider-trading-activity-7f63b85cedf4.html)[[3]](https://www.ainvest.com/news/insider-sale-principal-accounting-officer-irwd-sold-35-416-shares-2601/) On January 5, 2026, Silver sold 35,416 shares of Ironwood Class A Common Stock at $4.60 per share under a pre-arranged Rule 10b5-1 trading plan; these shares were acquired via the company's employee stock purchase plan on December 31, 2025. Following the transaction, he beneficially owned 276,809 shares directly.[[2]](https://www.stocktitan.net/sec-filings/IRWD/form-4-ironwood-pharmaceuticals-inc-insider-trading-activity-7f63b85cedf4.html)[[3]](https://www.ainvest.com/news/insider-sale-principal-accounting-officer-irwd-sold-35-416-shares-2601/) Silver has engaged in prior insider sales, including another transaction of 12,048 shares and a total of two sales amounting to 38,262 shares over recent months, reflecting routine activity among IRWD executives with no purchases reported in the past six months.[[3]](https://www.ainvest.com/news/insider-sale-principal-accounting-officer-irwd-sold-35-416-shares-2601/)[[5]](https://www.investing.com/news/insider-trading-news/ironwood-pharmaceuticals-principal-accounting-officer-sells-21204-in-stock-93CH-3866312)[[7]](https://www.insiderscreener.com/en/company/ironwood-pharmaceuticals-inc)

View full insider profile →

Trade Price

$3.73

Quantity

24,173

Total Value

$90,206.00

Shares Owned

252,636

Trade Date

Monday, February 23, 2026

4 days ago

SEC Filing Date

Wednesday, February 25, 2026

Filed 2 days after trade

HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

About Ironwood Pharmaceuticals Inc

Company Overview

No company information available
View news mentioning IRWD

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4295569

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime